Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 412 results for "amgen rank"

BLINCYTO Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia

Amgen presents positive data from phase 3 TOWER study of Blinc...

Amgen announced new data from a prespecified interim analysis of the phase 3 TOWER study, in which Blincyto (blinatumomab) demonstrated an almost two-fold increase in median overall survival (OS) compared to standard of care (SOC). The randomized, ... PharmaBiz, 3 weeks ago

Ben King grabs the Amgen Tour of California spotlight, winning Stage 2

A long strip of yellow caution tape held back dozens of people crowded around a nondescript recreational vehicle parked on Mission Street in South Pasadena not long before the Amgen Tour of California 's second stage started Monday. When Peter ...
 Los Angeles Times1 month ago

Analyst Rating Update: Amgen Inc. (NASDAQ:AMGN)

Wall Street analysts have placed a target price of $183.75 for Amgen Inc. (NASDAQ:AMGN). This number is based on the mean consensus estimate from the 12 research firms that recently issued reports on the stock. The average broker recommendation is ...
 Markets Daily2 weeks ago Analysts Set 1-Year Price Target Of $183.75 On Amgen Inc. (NASDAQ:AMGN) Stock  Markets Daily1 month ago Amgen Is Even More Attractive After Earnings  Seeking Alpha1 month ago
Mr Top Step

Amgen's Biosimilar of AbbVie's Humira to Face FDA Panel

Amgen Inc. AMGN announced that the FDA's Arthritis Advisory Committee will review data supporting the company's biologics license application for ABP 501, a biosimilar version of AbbVie Inc.'s ABBV best-selling drug, Humira. A final decision ...
 Yahoo! Singapore2 weeks ago

Novartis Reports Positive Data on Biosimilar Candidates

Novartis AG NVS announced results from two key studies comparing its proposed biosimilar versions of Amgen's AMGN blockbuster drug, Enbrel (etanercept), and Roche's RHHBY MabThera (rituximab) to the reference drugs at the Annual European Congress of ...
 Yahoo! Singapore3 weeks ago

PRIMECAP Odyssey Stock Fund (POSKX) in Focus

PRIMECAP Odyssey Stock ( POSKX ) a Zacks Rank #2 (Buy) seeks to provide long-term capital appreciaAtion. POSKX invests primarily in the common stocks of U.S. companies. POSKX invests the majority of its assets in stocks. This Large Growth fund, ...
 Zacks.com3 weeks ago

AMGEN : New National Survey Sheds Light on How to Better Engage Students in Science Education

American Students Want More Hands-on, Real-World Experiences. Teachers Are Critical to Inspiring a Lasting Interest in Science. THOUSAND OAKS, Calif., and WASHINGTON, June 7, 2016 /3BL Media/ The Amgen Foundation and Change the Equation (CTEq) today ...
 4 Traders3 weeks ago New National Survey Sheds Light on How To Better Engage Students in Science Education - Featured News  EdNet Insight.com3 weeks ago Survey: Students want engaging science instruction  ESchool News3 weeks ago

Intro Guide to the PRIMECAP Odyssey Growth Fund (POGRX)

PRIMECAP Odyssey Growth Fund ( POGRX ) a Zacks Rank #2 (Buy) was incepted in Nov 2004. The objective of POGRX is to seek long-term growth of capital. POGRX invests in common stocks of domestic companies with stable earnings growth potential. POGRX ...
 Zacks.com3 weeks ago

Merck, AbbVie & Amgen Drugs a Step Closer to EU Approval

Merck & Co. Inc. MRK , AbbVie Inc. ABBV and Amgen Inc. AMGN are all a step closer to gaining EU approval for their regulatory applications for Zepatier, Humira and Kyprolis, respectively. The companies announced that the Committee for Medicinal ...
 Zacks.com1 month ago

Vanguard PRIMECAP Core Investor Funds (VPCCX) in Focus

Vanguard PRIMECAP Core Investor Funds ( VPCCX ) a Zacks Rank #2 (Buy) was incepted in Dec 2004. VPCCX's main objective is to offer capital growth over the long run. VPCCX invests in stocks that are expected to provide impressive growth prospect and ...
 Zacks.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less